Creo Medical Group (CREO) Competitors GBX 12 0.00 (0.00%) As of 04/4/2025 12:19 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock CREO vs. EKF, IUG, NCYT, POLX, IHC, AVO, MHC, RUA, SUN, and BELLShould you be buying Creo Medical Group stock or one of its competitors? The main competitors of Creo Medical Group include EKF Diagnostics (EKF), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), MyHealthChecked (MHC), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), and Belluscura (BELL). These companies are all part of the "medical devices" industry. Creo Medical Group vs. EKF Diagnostics Intelligent Ultrasound Group Novacyt Polarean Imaging Inspiration Healthcare Group Advanced Oncotherapy MyHealthChecked RUA Life Sciences Surgical Innovations Group Belluscura EKF Diagnostics (LON:EKF) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings, analyst recommendations and community ranking. Does the MarketBeat Community favor EKF or CREO? EKF Diagnostics received 221 more outperform votes than Creo Medical Group when rated by MarketBeat users. Likewise, 76.76% of users gave EKF Diagnostics an outperform vote while only 67.52% of users gave Creo Medical Group an outperform vote. CompanyUnderperformOutperformEKF DiagnosticsOutperform Votes32776.76% Underperform Votes9923.24% Creo Medical GroupOutperform Votes10667.52% Underperform Votes5132.48% Does the media favor EKF or CREO? In the previous week, Creo Medical Group had 2 more articles in the media than EKF Diagnostics. MarketBeat recorded 2 mentions for Creo Medical Group and 0 mentions for EKF Diagnostics. EKF Diagnostics' average media sentiment score of 0.00 beat Creo Medical Group's score of -0.05 indicating that EKF Diagnostics is being referred to more favorably in the media. Company Overall Sentiment EKF Diagnostics Neutral Creo Medical Group Neutral Do insiders and institutionals hold more shares of EKF or CREO? 70.3% of EKF Diagnostics shares are held by institutional investors. Comparatively, 56.1% of Creo Medical Group shares are held by institutional investors. 5.2% of EKF Diagnostics shares are held by company insiders. Comparatively, 22.4% of Creo Medical Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, EKF or CREO? EKF Diagnostics has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500. Comparatively, Creo Medical Group has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500. Is EKF or CREO more profitable? EKF Diagnostics has a net margin of 9.37% compared to Creo Medical Group's net margin of -73.93%. EKF Diagnostics' return on equity of 7.03% beat Creo Medical Group's return on equity.Company Net Margins Return on Equity Return on Assets EKF Diagnostics9.37% 7.03% 5.27% Creo Medical Group -73.93%-41.79%-20.09% Which has preferable earnings and valuation, EKF or CREO? EKF Diagnostics has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEKF Diagnostics£49.91M1.88£4.68M£1.0719.64Creo Medical Group£33.87M1.43-£25.04M-£6.32-1.90 SummaryEKF Diagnostics beats Creo Medical Group on 12 of the 15 factors compared between the two stocks. Remove Ads Get Creo Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CREO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CREO vs. The Competition Export to ExcelMetricCreo Medical GroupMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£48.51M£3.24B£5.25B£2.42BDividend YieldN/A2.44%4.89%4.94%P/E Ratio-1.9075.4921.19127.51Price / Sales1.43122.05356.80260,717.02Price / Cash2.4315.9938.1828.06Price / Book0.923.626.244.36Net Income-£25.04M£126.02M£3.20B£5.81B7 Day Performance-7.69%-5.14%-8.30%2.03%1 Month Performance-12.73%-9.67%-4.70%0.16%1 Year Performance-67.93%-13.88%2.67%95.71% Creo Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CREOCreo Medical GroupN/AGBX 12flatN/A-67.7%£48.51M£33.87M-1.90279News CoverageHigh Trading VolumeEKFEKF DiagnosticsN/AGBX 23.02+12.3%N/A-22.4%£102.30M£49.91M21.42356High Trading VolumeIUGIntelligent Ultrasound GroupN/AN/AN/AN/A£42.76M£6.57M-18.9165NCYTNovacytN/AGBX 42.70-3.0%N/A-9.3%£29.50M£18.12M-0.78120Positive NewsGap DownPOLXPolarean ImagingN/AGBX 1.15-2.1%N/A-74.7%£16.88M£5.21M-0.3028Gap DownIHCInspiration Healthcare GroupN/AGBX 16.75+1.5%N/A-42.3%£14.51M£42.87M-1.15224Positive NewsGap DownAVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownMHCMyHealthCheckedN/AGBX 15.40+1.0%N/A+19.2%£8.01M£9.43M-7.6816RUARUA Life SciencesN/AGBX 12.05+0.4%N/A+4.0%£7.48M£4.05M-2.8148SUNSurgical Innovations GroupN/AGBX 0.56+1.5%N/A+4.6%£5.21M£12.54M-21.1180News CoverageGap UpBELLBelluscuraN/AGBX 1.50-4.8%N/A-85.7%£3.78M£2.87M-0.1624Gap UpHigh Trading Volume Remove Ads Related Companies and Tools Related Companies EKF Diagnostics Competitors Intelligent Ultrasound Group Competitors Novacyt Competitors Polarean Imaging Competitors Inspiration Healthcare Group Competitors Advanced Oncotherapy Competitors MyHealthChecked Competitors RUA Life Sciences Competitors Surgical Innovations Group Competitors Belluscura Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CREO) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creo Medical Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Creo Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CREO Stock Free CREO Stock Alerts